We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+26.72%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.52B
AUM Growth
+$1.41B
Cap. Flow
+$327M
Cap. Flow %
5.01%
Top 10 Hldgs %
29.27%
Holding
172
New
29
Increased
68
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$137M
2
VITL icon
Vital Farms
VITL
+$64.9M
3
YETI icon
Yeti Holdings
YETI
+$40.8M
4
GTM
ZoomInfo Technologies
GTM
+$36.8M
5
CWEN icon
Clearway Energy Class C
CWEN
+$32.9M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$84.7M
2
IPHI
INPHI CORPORATION
IPHI
+$51M
3
W icon
Wayfair
W
+$46.2M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$37.1M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.34%
2 Technology 25.33%
3 Industrials 10.16%
4 Consumer Discretionary 6.65%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIEN icon
101
Ciena
CIEN
$53.4B
$14.1M 0.22%
267,000
– –
DCPH
102
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$13.9M 0.21%
243,000
– –
CHMA
103
DELISTED
Chiasma, Inc. Common Stock
CHMA
$13.1M 0.2%
3,000,326
– –
MKC icon
104
McCormick & Company Non-Voting
MKC
$13.7B
$12.3M 0.19%
128,840
+3,640
+3% +$344K
ABCL icon
105
AbCellera Biologics
ABCL
$1.74B
$12.1M 0.19%
+300,000
New +$13.7M
LKFT
106
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$11.1M 0.17%
112,000
+61,000
+120% +$7.46M
A icon
107
Agilent Technologies
A
$39.1B
$11M 0.17%
92,500
+19,100
+26% +$2.11M
APTO
108
DELISTED
Aptose Biosciences, Inc.
APTO
$10.1M 0.15%
+5,109
New +$12M
FRC
109
DELISTED
First Republic Bank
FRC
$9.45M 0.14%
64,300
+25,100
+64% +$3.27M
PLD icon
110
Prologis
PLD
$135B
$9.08M 0.14%
91,100
+14,600
+19% +$1.48M
ITT icon
111
ITT
ITT
$17.5B
$9.07M 0.14%
117,800
+16,500
+16% +$1.15M
FHN icon
112
First Horizon
FHN
$12.2B
$8.85M 0.14%
693,700
+475,900
+219% +$5.58M
IMTX icon
113
Immatics
IMTX
$1.18B
$8.63M 0.13%
800,000
– –
FENC icon
114
Fennec Pharmaceuticals
FENC
$332M
$8.34M 0.13%
1,120,000
– –
DNTH icon
115
Dianthus Therapeutics
DNTH
$5.84B
$7.84M 0.12%
62,500
-84,978
-58% -$9.63M
ENTG icon
116
Entegris
ENTG
$18.1B
$7.46M 0.11%
77,629
+18,568
+31% +$1.62M
KNTE
117
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$6.96M 0.11%
+175,000
New +$7.02M
KLAC icon
118
KLA
KLAC
$239B
$6.6M 0.1%
254,980
+31,240
+14% +$728K
JKHY icon
119
Jack Henry & Associates
JKHY
$10.9B
$6.5M 0.1%
40,132
+13,632
+51% +$2.16M
STE icon
120
Steris
STE
$22.3B
$6M 0.09%
31,650
+2,450
+8% +$457K
ARE icon
121
Alexandria Real Estate Equities
ARE
$8.97B
$5.76M 0.09%
32,300
-4,800
-13% -$793K
CRNX icon
122
Crinetics Pharmaceuticals
CRNX
$8.84B
$5.64M 0.09%
400,000
-947,000
-70% -$13.2M
PNR icon
123
Pentair
PNR
$10.4B
$5.31M 0.08%
+100,100
New +$5.13M
SBAC icon
124
SBA Communications
SBAC
$19.2B
$4.93M 0.08%
+17,466
New +$5.13M
SNPS icon
125
Synopsys
SNPS
$74.4B
$4.49M 0.07%
17,309
+8,071
+87% +$1.86M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eventide Asset Management held 172 positions worth $6.52B, up 28% from $5.11B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $327M of net new capital in Q4 2020, opening 29 new positions and adding to 68 existing holdings. Its largest new stake was Praxis Precision Medicines: 234,205 shares worth $184M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $46.2M trimmed.

  • Eventide Asset Management's largest Q4 2020 buy was Praxis Precision Medicines: 234,205 shares worth $184M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q4 2020, an estimated $36.8M increase.
  • Eventide Asset Management's biggest Q4 2020 reduction was Wayfair, cutting an estimated $46.2M.
  • Eventide Asset Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $84.7M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $6.52B portfolio in Q4 2020.
  • Eventide Asset Management opened 29 new positions and closed 14 in Q4 2020.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $6.52B.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.